Generic drug
Capecitabine price, strengths & recalls
Pharmacies pay $13.61 for 30 tablets of Capecitabine 500 mg tablet this week, and from $10.85 to $13.61 across its 2 priced strengths and forms. 16 manufacturers make it. It has 5 recalls on record, none ongoing. Its official label last changed on May 13, 2026.
Generic- Fair cash price
- $26.15
- Strengths
- 2
- Makers
- 16
- Updated
- Nov 11
Capecitabine price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 150 mg tablet | $0.3615 | $10.85 / 30 tablets |
| 500 mg tablet | $0.4538 | $13.61 / 30 tablets |
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Capecitabine
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use CAPECITABINE TABLETS safely and effectively. See full prescribing information for CAPECITABINE TABLETS. CAPECITABINE tablets, for oral use Initial U.S. Approval: 1998
WARNING: SERIOUS ADVERSE REACTIONS OR DEATH IN PATIENTS WITH COMPLETE DPD DEFICIENCY and INCREASED RISK OF BLEEDING WITH CONCOMITANT USE OF VITAMIN K ANTAGONISTS
Increased risk of serious adverse reactions or death in patients with complete DPD deficiency
• Test patients for genetic variants of
DPYD prior to initiating capecitabine unless immediate treatment is necessary. Avoid use of capecitabine in patients with certain homozygous or compound heterozygous
DPYD variants that result in complete DPD deficiency
[see
Warnings and Precautions (5.1)]
.
Increased risk of bleeding with concomitant use of Vitamin K antagonists
• Altered coagulation parameters and/or bleeding, including death, have been reported in patients taking capecitabine concomitantly with oral vitamin K antagonists, such as warfarin
[see
Warnings and Precautions (5.2),
Drug Interactions (7.2)]
.
• Clinically significant increases in prothrombin time (PT) and international normalized ratio (INR) have been reported in patients who were on stable doses of a vitamin K antagonist at the time capecitabine was introduced. These events occurred in patients with and without liver metastases.
• Monitor INR more frequently and adjust the dose of the vitamin K antagonist as appropriate
[see
Drug Interactions (7.2)]
.
WARNING: SERIOUS ADVERSE REACTIONS OR DEATH IN PATIENTS WITH COMPLETE DPD DEFICIENCY and BLEEDING WITH CONCOMITANT USE OF VITAMIN K ANTAGONISTS
See full prescribing information for complete boxed warning.
Serious adverse reactions or death may occur in patients with complete DPD deficiency. Test patients for genetic variants of
DPYDprior to initiating Capecitabine tablet unless immediate treatment is necessary. Avoid use of Capecitabine tablet in patients with certain homozygous or compound heterozygous
DPYDvariants that result in complete DPD deficiency.
(5.1)
Altered coagulation parameters and/or bleeding, including death, have been reported in patients taking capecitabine concomitantly with oral vitamin K antagonists.
(5.2, 7.2) Monitor international normalized ratio (INR) more frequently and adjust the dose of the vitamin K antagonist as appropriate.
(7.2)
Recent major changes (as listed on the label)
Boxed Warning (10/2025)
Dosage and Administration (2.1) (10/2025)
Warnings and Precautions (5.1) (10/2025)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 10 approved generic applications on the market
Capecitabine questions
How much does capecitabine cost without insurance?
Pharmacies pay about $13.61 for 30 tablets of capecitabine 500 mg tablet ($0.4538 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $26.15. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is capecitabine in shortage?
No shortage is reported for capecitabine right now. We check the national shortage list every day.
Has capecitabine been recalled?
5 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the capecitabine label last change?
The official label was last updated on May 13, 2026 (version 3). See what changed.
Talk about capecitabine
No comments yet. Questions, tips, what worked for you - start the conversation.